{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:28:00Z","timestamp":1775896080687,"version":"3.50.1"},"reference-count":23,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,1]]},"abstract":"<jats:p>OBJECTIVES. Leukocyte adhesion deficiency is a rare primary immune disorder caused by defects of the CD18 \u03b2-integrin molecule on immune cells. The condition usually presents in early infancy and is characterized by deep tissue infections, leukocytosis with impaired formation of pus, and delayed wound healing. Allogeneic hematopoietic stem-cell transplantation offers the possibility of curative therapy, and with patient numbers at any individual center being limited, we surveyed the transplant experience at 14 centers worldwide.<\/jats:p>\n               <jats:p>METHODS. The course of 36 children with a confirmed diagnosis of leukocyte adhesion deficiency who underwent hematopoietic stem-cell transplantation between 1993 and 2007 was retrospectively analyzed. Data were collected by the registries of the European Society for Immunodeficiencies\/European Group for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research.<\/jats:p>\n               <jats:p>RESULTS. At a median follow-up of 62 months (extending to 14 years), the overall survival rate was 75%. Myeloablative conditioning regimens were used in 28 patients, and reduced-intensity conditioning in 8 patients, with no deaths in this subgroup. Survival rates after matched family donor and unrelated donor transplants were similar, with 11 of 14 matched family donor and 12 of 14 unrelated donor recipients alive; mortality was greatest after haploidentical transplants, after which 4 of 8 children did not survive. Twenty-seven transplant recipients were alive, with full donor engraftment in 17 cases, mixed multilineage chimerism in 7 patients, and mononuclear cell-restricted chimerism in an additional 3 cases.<\/jats:p>\n               <jats:p>CONCLUSIONS. Hematopoietic stem-cell transplantation offers long-term benefit in leukocyte adhesion deficiency and should be considered as an early therapeutic option if a suitable HLA-matched stem-cell donation is available. Reduced-intensity conditioning was particularly safe, and mixed-donor chimerism seems sufficient to prevent significant symptoms, although careful long-term monitoring will be required for these patients.<\/jats:p>","DOI":"10.1542\/peds.2008-1191","type":"journal-article","created":{"date-parts":[[2009,3,2]],"date-time":"2009-03-02T12:49:02Z","timestamp":1235998142000},"page":"836-840","source":"Crossref","is-referenced-by-count":99,"title":["Allogeneic Hematopoietic Stem-Cell Transplantation for Leukocyte Adhesion Deficiency"],"prefix":"10.1542","volume":"123","author":[{"given":"Waseem","family":"Qasim","sequence":"first","affiliation":[{"name":"Department of Immunology, Great Ormond Street Hospital, London, United Kingdom"}]},{"given":"Marina","family":"Cavazzana-Calvo","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ho\u0302pital Necker Enfants Malades, Paris, France"}]},{"given":"E. Graham","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Immunology, Great Ormond Street Hospital, London, United Kingdom"}]},{"given":"Jeffery","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada"}]},{"given":"Michel","family":"Duval","sequence":"additional","affiliation":[{"name":"Service d'Hemato-Oncologie, Hopital Sainte Justine, Montreal, Quebec, Canada"}]},{"given":"Gretchen","family":"Eames","sequence":"additional","affiliation":[{"name":"Department of Blood and Marrow Transplantation, Cook Children's Medical Center, Fort Worth, Texas"}]},{"given":"Nuno","family":"Farinha","sequence":"additional","affiliation":[{"name":"Hematology and Oncology Unit, Hospital de S. Joao, Porto, Portugal"}]},{"given":"Alexandra","family":"Filopovich","sequence":"additional","affiliation":[{"name":"Department of Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio"}]},{"given":"Alain","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ho\u0302pital Necker Enfants Malades, Paris, France"}]},{"given":"Wilhelm","family":"Friedrich","sequence":"additional","affiliation":[{"name":"Department of Blood and Marrow Transplantation, Universitaet Ulm, Ulm, Germany"}]},{"given":"Andrew","family":"Gennery","sequence":"additional","affiliation":[{"name":"Department of Immunology, Newcastle General Hospital, Newcastle-Upon-Tyne, United Kingdom"}]},{"given":"Carsten","family":"Heilmann","sequence":"additional","affiliation":[{"name":"Department of Blood and Marrow Transplantation, Rigshospitalet, Copenhagen, Denmark"}]},{"given":"Paul","family":"Landais","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ho\u0302pital Necker Enfants Malades, Paris, France"}]},{"given":"Mitchell","family":"Horwitz","sequence":"additional","affiliation":[{"name":"Division of Cellular Therapy, Duke University Medical Center, Durham, North Carolina"}]},{"given":"Fulvio","family":"Porta","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica, Universita\u0301 Degli Studi di Brescia, Brescia, Italy"}]},{"given":"Petr","family":"Sedlacek","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology and Oncology, University Hospital Motol, Prague, Czech Republic"}]},{"given":"Reinhard","family":"Seger","sequence":"additional","affiliation":[{"name":"Division of Immunology, Hematology, and Oncology, University Children's Hospital, Zu\u0308rich, Switzerland"}]},{"given":"Mary","family":"Slatten","sequence":"additional","affiliation":[{"name":"Department of Immunology, Newcastle General Hospital, Newcastle-Upon-Tyne, United Kingdom"}]},{"given":"Lochie","family":"Teague","sequence":"additional","affiliation":[{"name":"Paediatric Haematology and Oncology, Starship Children's Hospital, Auckland, New Zealand"}]},{"given":"Mary","family":"Eapen","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research Statistical Center, Medical College of Wisconsin, Milwaukee, Wisconsin"}]},{"given":"Paul","family":"Veys","sequence":"additional","affiliation":[{"name":"Department of Immunology, Great Ormond Street Hospital, London, United Kingdom"}]}],"member":"417","published-online":{"date-parts":[[2009,3,1]]},"reference":[{"key":"2021120902480963600_R1","unstructured":"Fischer A, Lisowska-Grospierre B, Anderson DC, Springer TA. Leukocyte adhesion deficiency: molecular basis and functional consequences. Immunodefic Rev.\u20081988;1(1):39\u201354"},{"key":"2021120902480963600_R2","doi-asserted-by":"crossref","unstructured":"Malech HL, Hickstein DD. Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency. Curr Opin Hematol.\u20082007;14(1):29\u201336","DOI":"10.1097\/00062752-200701000-00007"},{"key":"2021120902480963600_R3","doi-asserted-by":"crossref","unstructured":"Movahedi M, Entezari N, Pourpak Z, et al. Clinical and laboratory findings in Iranian patients with leukocyte adhesion deficiency (study of 15 cases). J Clin Immunol.\u20082007;27(3):302\u2013307","DOI":"10.1007\/s10875-006-9069-4"},{"key":"2021120902480963600_R4","doi-asserted-by":"crossref","unstructured":"Fischer A, Trung PH, Descamps-Latscha B, et al. Bone-marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonised particle phagocytosis. Lancet.\u20081983;2(8348):473\u2013476","DOI":"10.1016\/S0140-6736(83)90509-3"},{"key":"2021120902480963600_R5","doi-asserted-by":"crossref","unstructured":"Le Deist F, Blanche S, Keable H, et al. Successful HLA nonidentical bone marrow transplantation in three patients with the leukocyte adhesion deficiency. Blood.\u20081989;74(1):512\u2013516","DOI":"10.1182\/blood.V74.1.512.bloodjournal741512"},{"key":"2021120902480963600_R6","doi-asserted-by":"crossref","unstructured":"Thomas C, Le Deist F, Cavazzana-Calvo M, et al. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood.\u20081995;86(4):1629\u20131635","DOI":"10.1182\/blood.V86.4.1629.bloodjournal8641629"},{"key":"2021120902480963600_R7","doi-asserted-by":"crossref","unstructured":"Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968\u201399. Lancet.\u20082003;361(9357):553\u2013560","DOI":"10.1016\/S0140-6736(03)12513-5"},{"key":"2021120902480963600_R8","doi-asserted-by":"crossref","unstructured":"Rao K, Amrolia PJ, Jones A, et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood.\u20082005;105(2):879\u2013885","DOI":"10.1182\/blood-2004-03-0960"},{"key":"2021120902480963600_R9","doi-asserted-by":"crossref","unstructured":"Ho VT, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood.\u20082001;98(12):3192\u20133204","DOI":"10.1182\/blood.V98.12.3192"},{"key":"2021120902480963600_R10","doi-asserted-by":"crossref","unstructured":"Engel ME, Hickstein DD, Bauer TR Jr, Calder C, Manes B, Frangoul H. Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency. Bone Marrow Transplant.\u20082006;37(7):717\u2013718","DOI":"10.1038\/sj.bmt.1705301"},{"key":"2021120902480963600_R11","doi-asserted-by":"crossref","unstructured":"Takahashi D, Nagatoshi Y, Saito Y, et al. Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency. Bone Marrow Transplant.\u20082006;37(8):807\u2013808","DOI":"10.1038\/sj.bmt.1705336"},{"key":"2021120902480963600_R12","doi-asserted-by":"crossref","unstructured":"Tokunaga M, Miyamura K, Ohashi H, et al. Successful nonmyeloablative bone marrow transplantation for leukocyte adhesion deficiency type I from an unrelated donor. Int J Hematol.\u20082007;86(1):91\u201395","DOI":"10.1532\/IJH97.06209"},{"key":"2021120902480963600_R13","doi-asserted-by":"crossref","unstructured":"Farinha NJ, Duval M, Wagner E, et al. Unrelated bone marrow transplantation for leukocyte adhesion deficiency. Bone Marrow Transplant.\u20082002;30(12):979\u2013981","DOI":"10.1038\/sj.bmt.1703719"},{"key":"2021120902480963600_R14","doi-asserted-by":"crossref","unstructured":"Hattori H, Tsuruta S, Horikoshi Y, et al. Successful human leukocyte antigen one antigen-mismatched related bone marrow transplantation in a 6-year-old boy with leukocyte adhesion deficiency syndrome. Pediatr Int.\u20082001;43(3):306\u2013309","DOI":"10.1046\/j.1442-200x.2001.01381.x"},{"key":"2021120902480963600_R15","unstructured":"Stary J, Bartunkova J, Kobylka P, et al. Successful HLA-identical sibling cord blood transplantation in a 6-year-old boy with leukocyte adhesion deficiency syndrome. Bone Marrow Transplant.\u20081996;18(1):249\u2013252"},{"key":"2021120902480963600_R16","doi-asserted-by":"crossref","unstructured":"Burkholder TH, Colenda L, Tuschong LM, Starost MF, Bauer TR Jr, Hickstein DD. Reproductive capability in dogs with canine leukocyte adhesion deficiency treated with nonmyeloablative conditioning prior to allogeneic hematopoietic stem cell transplantation. Blood.\u20082006;108(5):1767\u20131769","DOI":"10.1182\/blood-2006-02-005645"},{"key":"2021120902480963600_R17","doi-asserted-by":"crossref","unstructured":"Uzel G, Tng E, Rosenzweig SD, et al. Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood.\u20082008;111(1):209\u2013218","DOI":"10.1182\/blood-2007-04-082552"},{"key":"2021120902480963600_R18","doi-asserted-by":"crossref","unstructured":"Tone Y, Wada T, Shibata F, et al. Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood.\u20082007;109(3):1182\u20131184","DOI":"10.1182\/blood-2006-08-039057"},{"key":"2021120902480963600_R19","doi-asserted-by":"crossref","unstructured":"Stephan V, Wahn V, Le Deist F, et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med.\u20081996;335(21):1563\u20131567","DOI":"10.1056\/NEJM199611213352104"},{"key":"2021120902480963600_R20","doi-asserted-by":"crossref","unstructured":"Ariga T, Kondoh T, Yamaguchi K, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol.\u20082001;166(8):5245\u20135249","DOI":"10.4049\/jimmunol.166.8.5245"},{"key":"2021120902480963600_R21","doi-asserted-by":"crossref","unstructured":"Creevy KE, Bauer TR Jr, Tuschong LM, et al. Mixed chimeric hematopoietic stem cell transplant reverses the disease phenotype in canine leukocyte adhesion deficiency. Vet Immunol Immunopathol.\u20082003;95(3\u20134):113\u2013121","DOI":"10.1016\/S0165-2427(03)00108-9"},{"key":"2021120902480963600_R22","doi-asserted-by":"crossref","unstructured":"Bauer TR Jr, Creevy KE, Gu YC, Tuschong LM, et al. Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency. Blood.\u20082004;103(9):3582\u20133589","DOI":"10.1182\/blood-2003-11-4008"},{"key":"2021120902480963600_R23","doi-asserted-by":"crossref","unstructured":"Bauer TR Jr, Allen JM, Hai M, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med.\u20082008;14(1):93\u201397","DOI":"10.1038\/nm1695"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/3\/836\/1067824\/zpe00309000836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/3\/836\/1067824\/zpe00309000836.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T15:47:01Z","timestamp":1639064821000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/123\/3\/836\/71679\/Allogeneic-Hematopoietic-Stem-Cell-Transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,1]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,1]]},"published-print":{"date-parts":[[2009,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-1191","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,1]]}}}